Close



Jan 8, 2024 05:23AM
Jan 7, 2024 05:45PM
Dec 28, 2023 04:15PM
Nov 16, 2023 09:00AM
Jan 9, 2023 04:59AM
Jan 8, 2023 05:00PM
Jan 3, 2023 08:00AM Ascendis Pharma to Present at the 41st Annual J.P. Morgan Healthcare Conference
Mar 16, 2022 06:47AM
Jan 10, 2022 08:00AM
Jan 4, 2022 08:00AM
Sep 29, 2021 04:01PM
Sep 29, 2021 04:01PM
Sep 2, 2021 05:23AM
Sep 1, 2021 07:43PM Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs
Aug 31, 2021 04:01PM
Aug 31, 2021 04:01PM
Mar 30, 2021 07:05AM
Jan 10, 2021 07:04PM
Jan 4, 2021 07:05AM
Jul 8, 2020 06:01AM
Jul 7, 2020 10:11PM Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs
Jul 6, 2020 01:00PM
Jul 6, 2020 12:58PM
Jan 12, 2020 07:45PM
Jan 9, 2020 04:00PM
Jun 26, 2019 12:50PM
Mar 6, 2019 05:57AM
Mar 5, 2019 08:07PM Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs
Mar 4, 2019 04:01PM
Mar 4, 2019 04:00PM
Mar 4, 2019 09:09AM
Jan 7, 2019 09:00AM
Dec 21, 2018 04:01PM
Nov 8, 2018 04:48PM
May 14, 2018 08:04AM Ascendis Pharma (ASND) Added to JPMorgan Analyst Focus List
Mar 21, 2018 06:25AM
Feb 21, 2018 11:45PM
Feb 20, 2018 04:02PM
Feb 20, 2018 04:01PM
Jan 8, 2018 08:00AM
Dec 21, 2017 04:05PM
Sep 27, 2017 05:38AM Ascendis Pharma (ASND) Prices 3.8M ADS Offering at $35.50/Sh
Sep 27, 2017 12:16AM
Sep 26, 2017 04:17PM
Sep 26, 2017 04:17PM
Sep 22, 2017 09:29AM
May 16, 2017 07:30AM
May 11, 2017 06:34AM
Jan 3, 2017 04:40PM Ascendis Pharma A/S Announces Presentation at 35th Annual J.P. Morgan Healthcare Conference on January 9
Oct 19, 2016 06:02AM

208,977 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All